ASH 2022 | Feasibility and safety of outpatient practice for recently approved CAR-T therapies
Radhika Bansal
• 11 Dec 2022
Radhika Bansal, MBBS, Mayo Clinic, Rochester, MN discusses a study evaluating the feasibility and safety of outpatient practice for patients receiving various CAR-T therapies. This study evaluated recently approved CAR-T therapies for multiple myeloma (MM), follicular lymphoma (FL) and mantle cell lymphoma (MCL), and it was demonstrated that outpatient practice is still feasible and safe. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
